about
Statistical comparison of dissolution profiles to predict the bioequivalence of extended release formulations.Challenges and opportunities in achieving bioequivalence for fixed-dose combination products.Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece.Innovative approaches for demonstration of bioequivalence: the US FDA perspective.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel methods to assess bioequivalence.
@en
Novel methods to assess bioequivalence.
@nl
type
label
Novel methods to assess bioequivalence.
@en
Novel methods to assess bioequivalence.
@nl
prefLabel
Novel methods to assess bioequivalence.
@en
Novel methods to assess bioequivalence.
@nl
P2860
P1476
Novel methods to assess bioequivalence.
@en
P2093
Mira Symillides
Panos Macheras
P2860
P356
10.1517/17425255.2011.539202
P407
P577
2010-12-01T00:00:00Z